Avantor (AVTR) Expected to Release Quarterly Earnings on Wednesday

Avantor (NYSE:AVTR) is projected to announce its Q3 2026 results before the market opens on Wednesday, October 28th. Analysts expect the company to post earnings of $0.2076 per share and revenue of $1.64 billion for the quarter. Avantor has set its FY 2026 guidance at 0.800-0.830 EPS. Parties can find conference call details on the company’s upcoming Q3 2026 earnings results page for the latest details on the call scheduled for Wednesday, October 28, 2026 at 8:00 AM ET.

Avantor (NYSE:AVTR) last announced its earnings results on Wednesday, July 29th. The company reported $0.21 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.19 by $0.02. The company had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.61 billion. Avantor had a positive return on equity of 9.92% and a negative net margin of 8.81%. Avantor’s revenue for the quarter was up .5% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.24 earnings per share. On average, analysts expect Avantor to post $0.81 EPS for the current fiscal year and $0.87 EPS for the next fiscal year.

Avantor Price Performance

NYSE AVTR opened at $16.65 on Wednesday. The company has a current ratio of 1.78, a quick ratio of 1.18 and a debt-to-equity ratio of 0.65. Avantor has a 1 year low of $7.26 and a 1 year high of $16.83. The company has a market cap of $11.26 billion, a PE ratio of -19.82, a PEG ratio of 9.26 and a beta of 0.94. The stock’s 50-day moving average price is $15.01 and its two-hundred day moving average price is $11.55.

Analyst Ratings Changes

AVTR has been the subject of several research reports. TD Cowen raised their price target on shares of Avantor from $15.00 to $17.00 and gave the stock a “hold” rating in a report on Tuesday, October 13th. Morgan Stanley upped their price objective on shares of Avantor from $14.00 to $15.00 and gave the company an “equal weight” rating in a research note on Tuesday, October 13th. Stifel Nicolaus upped their price objective on shares of Avantor from $8.00 to $15.00 and gave the company a “hold” rating in a research note on Thursday, July 30th. Citigroup increased their target price on shares of Avantor from $9.00 to $11.00 and gave the stock a “neutral” rating in a research report on Wednesday, July 8th. Finally, Wolfe Research raised shares of Avantor from a “strong sell” rating to a “hold” rating in a research note on Thursday, July 30th. Two research analysts have rated the stock with a Buy rating, fifteen have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $13.06.

About Avantor

Avantor, Inc is a global provider of mission-critical products and services used in the life sciences, healthcare, education, and advanced technology industries. The company supplies chemicals, reagents, laboratory consumables, equipment, and other materials used in research, development, manufacturing, and quality-control activities.

Avantor also provides specialized solutions for biopharmaceutical production, including materials and services that support drug development, biologics manufacturing, and other bioprocessing applications.